Home > Healthcare > Medical Devices > Diagnostic Devices > Pulse Oximeter Market

Pulse Oximeter Market Share

Report ID: GMI3843
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Pulse Oximeter Market Share

The market is fragmented in nature, with key market players, local players, and new start-ups joining the industry competition. The firms are engaged in innovative product launches to expand their product portfolio and extend their services to expand their customer base. Masimo Corporation is one of the significant market players, focuses on the development of products and strategic collaborations to grow in the market. For instance, In November 2021, Masimo Corporation announced the launch of Duel set pulse oximetry. This pulse oximeter aide in newborn congenital heart disease screening along with SpO2 saturation measurement.

Some of the eminent market participants operating in the pulse oximeter industry include:

Koninklijke Philips N.V.
Masimo Corporation
Medtronic plc
Nihon Kohden Corporation
Nonin Medical, Inc.
Omron Corporation
Smiths Group plc.
Contec Medical Systems Co., Ltd.
ChoiceMMed
Dr Trust
Guangdong Biolight Medical Technology Co., Ltd.
Shanghai Berry Electronic Technology Co., Ltd.
Beurer GmbH

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Pulse oximeter industry size was USD 2.7 billion in 2022 and is estimated to witness 6.5% CAGR, reaching over USD 4.7 billion by 2032 due to the surging prevalence of respiratory diseases worldwide.

Table-top/bedside pulse oximeters market size is likely to cross USD 1,555 million by 2032 attributed to the increasing prevalence of chronic and acute respiratory diseases.

Pulse oximeter market size from hospitals and clinics is anticipated to exceed USD 3,287 million by 2032 attributed to the increasing patient preference for quality care and speedy.

U.S. pulse oximeter industry size was USD 1,027 million in 2022 and is predicted to record notable growth up to 2032 due to the increasing prevalence of chronic respiratory conditions, supportive government initiatives and surging awareness for point-of-care testing.